Pioneering Patient Assessment Tools

for the measurement of neurological and motor function.

self-administered

clinically-validated

easily integrated

Qr8: A digital health company

Our vision is to enable transformational improvement in patient care by providing medical devices for collecting highly standardized clinical data and patient-reported outcomes, in any medical or home setting.

A Platform Technology

Qr8 Health’s platform technology incorporates standardized, validated digital tests for the measurement of neurological and motor function along with patient reported outcomes that are self-administered on a mobile tablet device and easily integrated into electronic health records.

 

Our platform technology has future potential in the detection and treatment of:

Alzheimer's

Alzheimer's

Parkinson's

Parkinson's

Stroke

Stroke

Heart Failure

Heart Failure

Multiple Sclerosis Performance Test

The first example of our platform in clinical use is the Multiple Sclerosis Performance Test (MSPT), an iPad-based assessment tool designed to objectively quantify major motor, visual, and cognitive symptoms for patients with multiple sclerosis. The MSPT is administered during routine clinical visits and test results are automatically posted to the patient’s electronic health record.

 

MSPT is current being utilized by the Cleveland Clinical Mellen Center for Multiple Sclerosis and in over 50 multiple sclerosis centers globally.

Woman with Icons around her

Transformational Clinical Data Collection

  • Clinically-meaningful and validated measures in digital format
  • Collects patient-reported outcomes and patient-entered data
  • Self-administered by patients
  • Enables aggregation of data to characterize and track large target patient populations
  • Standardized functional assessments easily integrated into clinical practice

World-Class Patient Care

  • Allows advanced collection of functional measurement and patient-entered data designed to improve clinical outcomes
  • Enables data tracking over time to better facilitate treatment or behavioral interventions
  • Patient-friendly software facilitates clear communication between patient and physician
Doctor and Patient
Three Workers at a Table

Economic Efficiency

  • High-quality data collection without excess burden on clinical staff
  • Enables immediate access to patient data at the point of care
  • Full electronic medical record (EMR) integration using SMART on FHIR approach

Our Products 

Information processing speed can be impacted by neurological disorders such as Alzheimer’s disease and Parkinson’s disease. Identification is important as processing speed impairment can potentially be modified with cognitive training and future therapeutic intervention.

PST Snapshot™

  • An FDA registered cognitive function test that rapidly measures information processing speed
  • Digital application based on the symbol-digit modalities test (SDMT), a symbol substitution neuropsychological test that examines a person’s attention and speed of processing
  • Patient self-administered assessment completed in under five minutes
  • Results are automatically scored and norm-adjusted based on demographic variables such as age and level of education
Processing Speed TestBy Rx only

Cognition Snapshot™

Cognition Snapshot Information processing speed and memory are often negatively affected in many neurological disorders and are important to identify early. Cognition Snapshot™ is an FDA registered digital application that quickly evaluates processing speed, spatial & verbal memory for use in all patient groups.

Cognition Snapshot™

  • Rapidly measures cognitive domains which are particularly sensitive during mild cognitive impairment (MCI)
  • Contains two test modules, the processing speed test (PST) and the visual memory test (VMT) which have been validated against the symbol-digit modalities test (SDMT) and the 7/24 spatial recall test respectively
  • Validated to be fully patient self-administered through step by step tutorial
  • Results are automatically scored and norm-adjusted based on demographic variables

News

2020

Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules

Rao, S., Galioto, R., Sokolowski et al. Eur J Neurol 2020 Feb 3

2019

Technology-enabled assessments to enhance multiple sclerosis clinical care and research

Gabrielle Macaron, Brandon P. Moss, Hong Li et al. Neurol Clin Pract Sept 2019, 10.1212

2017

Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinical setting

Rao S., Losinski G., Mourany L., et al. | Mult Scier 2017 Dec;23(14):1929-1937